Inclusion Criteria:

1. The inclusion criteria are as follows: ① meeting the above-mentioned integrated Chinese and Western medicine diagnostic criteria for DOR
2. ② no use of estrogen-containing medications within the past 1 month
3. ③ patients scheduled to undergo IVF-ET
4. ④ provision of signed informed consent, voluntary participation, and good compliance.

Exclusion Criteria:

1. The exclusion criteria are as follows: ① patients with polycystic ovary syndrome (PCOS) or stage III/IV endometriosis
2. ② uterine conditions including untreated submucous myomas, intramural myomas >4 cm in diameter, intrauterine adhesions, uterine septum, or other uterine anomalies
3. ③ couples undergoing preimplantation genetic diagnosis (PGD) for genetic reasons
4. ④ body mass index (BMI) ≥28 kg/m²
5. ⑤ history of prior pelvic radiotherapy or cytotoxic chemotherapy
6. ⑥ significant systemic diseases, such as uncontrolled hypertension, diabetes mellitus, thyroid dysfunction, hepatic or renal insufficiency, cardiac disorders, or autoimmune diseases
7. ⑦ use of medications that may interfere with this study within the past 1 month, including but not limited to estrogens, hepatic enzyme modulators, and agents that may affect the endocrine system (hormonal drugs)
8. ⑧ known allergy to any components of the study medication
9. and ⑨ participation in another drug trial within the past 3 months. -